Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere

@article{Pebody2017LiveAI,
  title={Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere},
  author={Richard G. Pebody and Jim McMenamin and Hanna Nohynek},
  journal={Archives of Disease in Childhood},
  year={2017},
  volume={103},
  pages={101 - 105}
}
The USA has a long-standing paediatric influenza vaccination programme, including use of live attenuated influenza vaccine (LAIV). Following US evidence of apparent lack of vaccine effectiveness (VE) of LAIV in 2015/2016, particularly against A(H1N1)pdm09, the USA suspended the use of LAIV in the 2016/2017 season. The UK introduced LAIV for children in 2013/2014 and Finland in 2015/2016. Both countries have since been closely monitoring programme performance. In 2015/2016, the UK and Finland… 

Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study

There was no evidence to support the lack of effectiveness of LAIV against influenza A(H1N1)pdm09 and the results support administration of either vaccine type in this age group, and the relative effectiveness of each vaccine type was assessed.

Live Attenuated and Inactivated Influenza Vaccine Effectiveness

Reduced effectiveness of LAIV4 against influenza A/H1N1pdm09 compared with IIV is found, which is consistent with published results from the individual studies included.

Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016–2017 and 2017–2018 Influenza Seasons in the United Kingdom

The (H1N1)pdm09 titer increased in 2017–2018, indicating more efficient virus replication in shedding-positive children than the 2016–2017 strain, although overall positivity was reduced.

Effectiveness of two influenza vaccines in nationwide cohorts of Finnish two-year-old children in the seasons 2015/16-2017/18.

The vaccination program in Finland now recommends LAIV4 and injectable, tetravalent inactivated influenza vaccines replacing IIV3, and both of the influenza vaccines clearly excelled in protecting children.

End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17

  • R. PebodyF. Warburton M. Zambon
  • Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2017
The findings continue to provide support for the ongoing roll-out of the paediatric vaccine programme, with a need for ongoing evaluation.

Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children

Different patterns for different antigens are found in immune responses to different viral strains included in the vaccine, suggesting that the response is multi‐factorial.

Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice

LAIV provides early protection against homologous and heterologous viral infections and has a protective effect against post-influenza pneumococcal infection and the intranasal administration of LAIV may be useful during the cycle of circulation of influenza viruses, but also of other causative agents of acute respiratory infections.
...

References

SHOWING 1-10 OF 33 REFERENCES

Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds – a nationwide cohort study Finland, influenza season 2015/16

This study provides evidence of moderate effectiveness against any laboratory-confirmed influenza of the quadrivalent LAIV vaccine as well as the inactivated trivalent vaccine among two-year-olds during the influenza season 2015/16 in Finland.

Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis

Findings confirm that effectiveness of LAIV against A(H1N1)pdm09 strains has been lower than IIV, which is less effective than inactivated influenza vaccine (IIV).

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine

Lower effectiveness of LAIV compared with IIV is observed but not A(H3N2) or B among children and adolescents, suggesting poor performance related to the LAIV A/H1N1pdm09 viral construct.

Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).

This report summarizes recommendations by the Advisory Committee on Immunization Practices (ACIP) for using intranasally administered, trivalent, cold-adapted, live, attenuated influenza vaccine

Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results

  • R. PebodyF. Warburton M. Zambon
  • Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2016
Estimates demonstrate moderate to good levels of protection, particularly against influenza B in children, but relatively less against influenza A(H1N1)pdm09, which provides reassurance for the UK to continue its influenza immunisation programme planned for 2016/17.

Prevention and Control of Seasonal Influenza with Vaccines.

  • L. GrohskopfL. Sokolow J. Bresee
  • Medicine
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
  • 2016
In light of concerns regarding low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013-14 and 2015-16 seasons, ACIP makes the interim recommendation that live attenuated influenza vaccine (LAIV4) should not be used.

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

During 2013-2014, IIV was significantly effective against A(H1N1)pdm09, and lack of LAIV4 effectiveness in children highlights the importance of continued annual monitoring of effectiveness of influenza vaccines in the United States.

Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines

  • C. AmbroseH. BrightR. Mallory
  • Biology, Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2016
Assumptions that vaccine–virus interference in the quadrivalent formulation, preexisting anti-influenza immunity from prior influenza vaccinations, and poor thermostability of A(H1N1)pdm09 LAIV strains are evaluated.

Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season

  • R. PebodyBersabeh Sile N. Andrews
  • Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2017
Live attenuated influenza vaccine effectiveness against laboratory-confirmed influenza hospitalisation in 2 to 6 year-olds in England was measured in 2015/16 using the screening method and the findings support on-going programme roll-out.